This is the authors' abstract. We don't add key points for this paper.
The sensitive and accurate detection methods for PEDV antibody have practical significance for the prevention and treatment of PEDV. In this work, a new multiple pathways signal amplification method was proposed to construct a sensitive electrochemiluminescence (ECL) platform for the detection of PEDV antibody. Using Au NP-modified graphene nanosheet (Au-GN) as the substrate, antibody–antigen reaction as the recognition unit, rolling circle amplification (RCA) for signal enhancement, and assembled cascade Ru-DNA nanotags as signal label, the proposed platform behaved with good specificity and sensitivity. The binding system of biotin–streptavidin, RCA, and Ru(bpy) 3 2+ -doped silica nanoparticles (Ru SNPs) showed remarkable amplification efficiency, low background signal, and little nonspecific adsorption. Moreover, the proposed ECL sensor exhibited good analytical performance for PEDV antibody with a wide linear range from 0.1 pg mL –1 to 5000 pg mL –1 with a detection limit of 0.05 pg mL –1 ( S / N = 3). The proposed strategy exhibited the advantages of excellent stability and sensitivity for determination of the PEDV antibody, which was easy to prepare and had a good application prospect.
Answers are grounded in this paper and cite their sources.
The proposed ECL platform provides a highly sensitive and specific method for detecting PEDV antibodies, which may aid in the prevention and treatment of PEDV.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: